Spearhead Capital Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,929
| Closed | -$302K | – | 194 |
|
|
2021
Q4 | $302K | Buy |
12,929
+300
| +2% | +$7.01K | 0.04% | 146 |
|
|
2021
Q3 | $210K | Sell |
12,629
-122
| -1% | -$2.03K | 0.03% | 180 |
|
|
2021
Q2 | $311K | Buy |
+12,751
| New | +$311K | 0.04% | 175 |
|
|
2021
Q1 | – | Sell |
-5,547
| Closed | -$297K | – | 186 |
|
|
2020
Q4 | $297K | Buy |
5,547
+164
| +3% | +$8.78K | 0.05% | 140 |
|
|
2020
Q3 | $222K | Buy |
5,383
+364
| +7% | +$15K | 0.04% | 172 |
|
|
2020
Q2 | $243K | Buy |
+5,019
| New | +$243K | 0.05% | 133 |
|